ETH
NAMSW icon

Exos TFP Holdings’s NewAmsterdam Pharma Warrant NAMSW Stock Holding History

Exos TFP Holdings’s Portfolio NAMSW Stock Details NAMSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-12,273
Closed -$23.3K – 193
2023
Q3 		$23.3K Sell
12,273
-10,000
-45% -$19.4K 0.01% 136
2023
Q2 		$46.6K Sell
22,273
-71,659
-76% -$154K 0.02% 123
2023
Q1 		$173K Sell
93,932
-43,385
-32% -$68.8K 0.04% 254
2022
Q4 		$119K Buy
+137,317
New +$113K 0.03% 278

Other funds holding NAMSW

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Exos TFP Holdings's NAMSW Position: Q4 2023 in Review

Exos TFP Holdings sold out of NewAmsterdam Pharma Warrant (NAMSW) in Q4 2023, closing a stake of 12,273 shares — an estimated $23.3K sold.

Exos TFP Holdings first reported a position in NAMSW in Q4 2022 and held it in 4 quarters. The position peaked at $173K in Q1 2023. 18 funds tracked by Wall St. Rank hold NAMSW as of Q4 2023.

  • Exos TFP Holdings reported no remaining NewAmsterdam Pharma Warrant position as of Q4 2023 after selling out during the quarter.
  • Exos TFP Holdings sold 12,273 NewAmsterdam Pharma Warrant shares in Q4 2023, an estimated $23.3K.
  • Exos TFP Holdings first reported a position in NewAmsterdam Pharma Warrant in Q4 2022 and held it in 4 quarters.
  • Exos TFP Holdings's NewAmsterdam Pharma Warrant position peaked at $173K in Q1 2023.
  • 18 funds tracked by Wall St. Rank held NewAmsterdam Pharma Warrant as of Q4 2023.

Based on Exos TFP Holdings's 13F filing for Q4 2023, filed 14 Feb 2024.